Filtered By:
Source: International Journal of Cardiology
This page shows you your search results in order of relevance. This is page number 8.
Order by Relevance | Date
Total 880 results found since Jan 2013.
The relationship between dietary magnesium intake, stroke and its major risk factors, blood pressure and cholesterol, in the EPIC-Norfolk cohort
This study aimed to investigate if dietary magnesium intake was associated with BP, total cholesterol (TC) and incident stroke risk in an adult population.
Source: International Journal of Cardiology - May 30, 2015 Category: Cardiology Authors: Lucy K.M. Bain, Phyo K. Myint, Amy Jennings, Marleen A.H. Lentjes, Robert N. Luben, Kay-Tee Khaw, Nick J. Wareham, Ailsa A. Welch Source Type: research
Predictors of new onset atrial fibrillation during 10-year follow-up after first-ever ischemic stroke
: Paroxysmal atrial fibrillation (AF) may be underdiagnosed in ischemic stroke patients but may be pivotal for initiation of oral anticoagulation therapy. We assessed clinical and ECG predictors of new-onset AF during 10-year follow-up (FU) in ischemic stroke patients.
Source: International Journal of Cardiology - July 14, 2015 Category: Cardiology Authors: Maria A. Baturova, Arne Lindgren, Jonas Carlson, Yuri V. Shubik, S. Bertil Olsson, Pyotr G. Platonov Source Type: research
Difference in autonomic nervous activity in different subtypes of noncardioembolic ischemic stroke
Arrhythmias, elevated blood pressure (BP), ischemic heart damage, and autonomic dysfunction are cardiovascular complications sometimes seen during the acute phase of stroke [1,2]. Autonomic nervous activity is most commonly assessed by heart rate variability (HRV) [3], which is reported to be reliable in patients after ischemic stroke [4].
Source: International Journal of Cardiology - July 30, 2015 Category: Cardiology Authors: Masashi Kanai, Hiroki Kubo, Yuka Kitamura, Kazuhiro P. Izawa, Kumiko Ono, Hiroshi Ando, Masafumi Nozoe, Kyoshi Mase, Shinichi Shimada Tags: Letter to the Editor Source Type: research
REal-LIfe Evidence of stroke prevention in patients with atrial Fibrillation – the RELIEF study
The objective of the ‘REal-LIfe Evidence on stroke prevention in patients with atrial Fibrillation’ (RELIEF) study was to compare the effectiveness of newly-initiated rivaroxaban or VKA therapy among NVAF patients in Germany.
Source: International Journal of Cardiology - September 21, 2015 Category: Cardiology Authors: Craig I. Coleman, Matthias Antz, Birgit Ehlken, Thomas Evers Source Type: research
Risk of major cardiovascular events in patients with hemodialysis or peritoneal dialysis with special reference to stroke
Kim et al. determined the incidence rates of major adverse cardiac and cerebrovascular events (MACCE) and compared several types of events between hemodialysis (HD) patients and peritoneal dialysis (PD) patients [1]. The authors handled 22,892 HD patients and 7,387 PD patients in Korea by intention-to-treat method, and median follow-up period was 21.5 months. The risk of several cardiac events in PD patients was significantly higher than that in HD patients. In contrast, the incidence rate of non-fatal hemorrhagic stroke in HD patients showed significantly higher than that in PD patients, and there was no significant diffe...
Source: International Journal of Cardiology - September 21, 2015 Category: Cardiology Authors: Tomoyuki Kawada Source Type: research
Left atrial appendage occlusion in atrial fibrillation for stroke prevention: A Systemic Review
Atrial fibrillation (AF) is an arrthymias characterized by increased risk of ventricle arrthymias and thromboembolism especially ischemic stroke. Most thrombus originated in left atrial appendage, thus left atrial occlusion (LAAO) may be an effective alternative for stroke prevention in atrial fibrillation.
Source: International Journal of Cardiology - October 5, 2015 Category: Cardiology Authors: Xianhui Zhou, Wenhui Zhang, Wenkui Lv, Qina Zhou, Yaodong Li, Ling Zhang, Yanmei Lu, Jianghua Zhang, Qiang Xing, Hongli Wang, Baopeng Tang Source Type: research
Importance of P-wave indices in stroke
I read with great interest the article by Pirinen et al. published in November, 2015 issue of the International journal of Cardiology [1]. In their study, the authors investigated the association of ECG findings with an etiological group of high risk source of cardioembolism (HRCE) in a cohort of young patients who experienced their first episode of ischemic stroke. Authors observed that patients experiencing cardioembolic stroke had a higher prevalence of increased P-wave duration (13%) and increased P-terminal force (PTF) of 40mm.ms(4%) [1].
Source: International Journal of Cardiology - November 17, 2015 Category: Cardiology Authors: Lovely Chhabra Source Type: research
REal-LIfe Evidence of stroke prevention in patients with atrial Fibrillation — The RELIEF study
The objective of the ‘REal-LIfe Evidence on stroke prevention in patients with atrial Fibrillation’ (RELIEF) study was to compare the effectiveness of newly-initiated rivaroxaban or VKA therapy among NVAF patients in Germany.
Source: International Journal of Cardiology - September 21, 2015 Category: Cardiology Authors: Craig I. Coleman, Matthias Antz, Birgit Ehlken, Thomas Evers Tags: Correspondence Source Type: research
Randomized trials of closure of persistant foramen ovale (PFO) vs medical therapy for patients with cryptogenic stroke – effect of lost-to-follow-up and withdrawal of consent
Foramen ovale is a remnant of the fetal circulation that can be found in all newly born infants and that remain open in about a quarter of adults and the presence of a persistent, or patent, foramen ovale, PFO is associated with cryptogenic stroke [1]. In several observational case-series, cohort studies and registries, device closure of PFO is associated with a significantly lower risk of recurrent stroke or transitory ischemia attacks, TIAs. In the three until today published randomized trials this has not been corroborated however [2–4].
Source: International Journal of Cardiology - January 14, 2016 Category: Cardiology Authors: Mikael Dellborg, Peter Eriksson Source Type: research
Randomized trials of closure of persistent foramen ovale (PFO) vs medical therapy for patients with cryptogenic stroke — Effect of lost-to-follow-up and withdrawal of consent
Foramen ovale is a remnant of the fetal circulation that can be found in all newly born infants and that remain open in about a quarter of adults and the presence of a persistent, or patent, foramen ovale, PFO is associated with cryptogenic stroke [1]. In several observational case-series, cohort studies and registries, device closure of PFO is associated with a significantly lower risk of recurrent stroke or transitory ischemia attacks, TIAs. In the three until today published randomized trials this has not been corroborated however [2–4].
Source: International Journal of Cardiology - January 14, 2016 Category: Cardiology Authors: Mikael Dellborg, Peter Eriksson Tags: Correspondence Source Type: research
Novel composite score to predict atrial Fibrillation in acute stroke patients
The objective of the present study was to construct a model that can predict the presence of atrial fibrillation in ischemic stroke patients and to validate the model.
Source: International Journal of Cardiology - February 2, 2016 Category: Cardiology Authors: Woo-Keun Seo, Sung-Hoon Kang, Jin-Man Jung, Jeong-Yoon Choi, Kyungmi Oh Source Type: research
Fatal stroke following treatment with apixaban in a patient with atrial fibrillation and left atrial appendage thrombus
Atrial fibrillation increases the risk of ischemic stroke 4–5 fold [1] and doubles the mortality independently of other vascular risk factors [2]. The vast majority (>90%) of thrombi associated with atrial fibrillation originate from the left atrial appendage [3]. The direct factor Xa inhibitor apixaban is superior to warfarin in terms of stroke prevention with a lower risk of bleeding and mortality [4].
Source: International Journal of Cardiology - March 23, 2016 Category: Cardiology Authors: Ashkan Eftekhari, Dorte Damgaard, Erik L. Grove Tags: Correspondence Source Type: research
Is left atrial appendage closure useful for stroke prevention in atrial fibrillation patients with renal failure?
With great interest we read the article by Kefer et al. about the impact of chronic kidney disease on left atrial appendage (LAA) occlusion with the ACP device for stroke prevention in patients with atrial fibrillation (AF) [1]. We agree with the authors that stroke prevention in AF patients with chronic kidney disease is a problem due to increased bleeding complications during oral anticoagulant therapy with vitamin K antagonists. Furthermore, the use of non-vitamin K-antagonist oral anticoagulants (NOACs) is dangerous or contraindicated in these patients.
Source: International Journal of Cardiology - April 14, 2016 Category: Cardiology Authors: Claudia Stöllberger, Josef Finsterer, Birke Schneider Source Type: research
What is the association of lipid levels and incident stroke?
The association between lipid levels and stroke rates is less than lipid levels and coronary heart disease (CHD)ObjectiveTo assess if there are geographic, racial, and ethnic differences in total cholesterol (TC), low density lipoprotein cholesterol (LDL-C), high density lipoprotein cholesterol(HDL-C) and triglyceride levels with incident stroke.
Source: International Journal of Cardiology - June 22, 2016 Category: Cardiology Authors: Stephen P. Glasser, Aleena Mosher, George Howard, Maciej Banach, Aleena Mosher Source Type: research
Impact of Systolic Blood Pressure on Hemorrhagic Stroke in Patients with Coronary Artery Disease During Anti-platelet Therapy: The Japanese Coronary Artery Disease (JCAD) Study
Hemorrhagic stroke is the most disastrous complication during anti-platelet therapy. Aggressive anti-platelet therapy, such as dual anti-platelet therapy (DAPT); dual therapy (DT), i.e. a combination of single anti-platelet therapy (SAPT) and an anti-coagulant therapy; and triple therapy (TT), i.e. a combination of DAPT and an anti-coagulant therapy, has become widespread in patients with coronary artery disease (CAD) [1 –3]. In patients with cerebrovascular diseases, DAPT has a greater risk of hemorrhagic stroke as compared with SAPT [4].
Source: International Journal of Cardiology - September 8, 2016 Category: Cardiology Authors: Hisashi Kai, Takahide Kohro, Kenji Fukuda, Tsutomu Yamazaki, Ryozo Nagai Tags: Correspondence Source Type: research
